Addex Therapeutics Ltd
ADXN8.849USD
+0.749+9.24%
시장 운영 시간 （ET）시세는 15분 지연됩니다
7.25M시가총액
0.96P/E TTM
자세한 내용은 Addex Therapeutics Ltd 회사
Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Company’s clinical programs pipeline include dipraglurant (mGlu5 NAM), which is Phase 2a placebo-controlled clinical trial for Parkinson's disease levodopa-induced dyskinesia (PD-LID), and is being prepared to enter registration trials for PD-LID, and ADX71149 (mGlu2 positive allosteric modulator or PAM), which is being developed in collaboration by its partner Janssen Pharmaceuticals, Inc to treat schizophrenia and anxious depression. It also is advancing several preclinical programs, including GABABPAM for pain, overactive bladder and other disorders, mGlu7 NAM for post-traumatic stress disorder, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson’s disease and mGlu3 PAM for neurodegenerative disorders.
회사 정보
종목 코드 ADXN
회사 이름Addex Therapeutics Ltd
상장일May 22, 2007
CEOMr. Tim Dyer
직원 수2
유형Ordinary Share
회계 연도 종료May 22
주소Chemin des Mines, 9
도시PLAN-LES-OUATES
증권 거래소SIX Swiss Exchange
국가Switzerland
우편 번호1202
전화41228841555
웹사이트https://www.addextherapeutics.com/en/
종목 코드 ADXN
상장일May 22, 2007
CEOMr. Tim Dyer
회사 임원
이름
이름/직위
직위
주식 보유
변동
Dr. Mikhail Kalinichev
Dr. Mikhail Kalinichev
Member of the Executive Management, Head of Translational Science
Member of the Executive Management, Head of Translational Science
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Lenaic Teyssedou
Mr. Lenaic Teyssedou
Member of the Executive Management, Head of Finance
Member of the Executive Management, Head of Finance
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
Dr. Isaac Manke
Dr. Isaac Manke
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Dr. Roger G. Mills
Dr. Roger G. Mills
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
Member of the Executive Management, Chief Medical Officer, Member of the Board of Directors
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Mikhail Kalinichev
Dr. Mikhail Kalinichev
Member of the Executive Management, Head of Translational Science
Member of the Executive Management, Head of Translational Science
--
--
Dr. Raymond G. (Ray) Hill
Dr. Raymond G. (Ray) Hill
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Lenaic Teyssedou
Mr. Lenaic Teyssedou
Member of the Executive Management, Head of Finance
Member of the Executive Management, Head of Finance
--
--
Dr. Vincent Lawton
Dr. Vincent Lawton
Independent Non-Executive Chairman of the Board of Directors
Independent Non-Executive Chairman of the Board of Directors
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Non-Executive Independent Member of the Board of Directors
Non-Executive Independent Member of the Board of Directors
--
--
Mr. Tim Dyer
Mr. Tim Dyer
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
Chief Executive Officer, Co-Founder, Member of the Executive Management, Director
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Sun, Feb 23
마지막 업데이트: Sun, Feb 23
주주
주주 유형
주주
주주
비율
Citadel Advisors LLC
1.10%
GAMMA Investing LLC
0.01%
Other
98.89%
주주
주주
비율
Citadel Advisors LLC
1.10%
GAMMA Investing LLC
0.01%
Other
98.89%
주주 유형
주주
비율
Hedge Fund
1.10%
Investment Advisor/Hedge Fund
0.01%
Other
98.89%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
12
12.04K
1.13%
-165.56K
2025Q1
16
13.11K
1.23%
-176.53K
2024Q4
17
15.10K
1.41%
-160.92K
2024Q3
22
37.43K
5.74%
-146.56K
2024Q2
21
38.45K
5.90%
-143.53K
2024Q1
20
36.44K
5.64%
-145.16K
2023Q4
19
195.87K
20.93%
+138.26K
2023Q3
18
73.39K
96.72%
+38.94K
2023Q2
18
50.23K
7.45%
-253.79K
2023Q1
17
333.00K
49.67%
+248.23K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Citadel Advisors LLC
11.74K
1.1%
-338.00
-2.80%
Mar 31, 2025
GAMMA Investing LLC
1.19K
0.11%
+182.00
+18.00%
Mar 31, 2025
Morgan Stanley & Co. LLC
100.00
0.01%
-1.80K
-94.74%
Mar 31, 2025
Rhumbline Advisers Ltd. Partnership
72.00
0.01%
-35.00
-32.71%
Mar 31, 2025
SBI Securities Co., Ltd.
5.00
0%
--
--
Mar 31, 2025
J. Stern & Co. LLP
--
0%
-107.83K
-100.00%
Mar 31, 2024
Armistice Capital LLC
--
0%
-43.00K
-100.00%
Mar 31, 2024
Baader Bank AG
--
0%
-960.00
-100.00%
Dec 31, 2023
Jane Street Capital, L.L.C.
--
0%
-529.00
-100.00%
Dec 31, 2023
New Enterprise Associates (NEA)
--
0%
-9.00K
-100.00%
Mar 31, 2024
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
날짜
유형
비율
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
Oct 06, 2023
Merger
20<1
